Matthieu Blanchet

681 total citations
19 papers, 550 citations indexed

About

Matthieu Blanchet is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Matthieu Blanchet has authored 19 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 12 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Matthieu Blanchet's work include Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (11 papers) and Viral gastroenteritis research and epidemiology (3 papers). Matthieu Blanchet is often cited by papers focused on Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (11 papers) and Viral gastroenteritis research and epidemiology (3 papers). Matthieu Blanchet collaborates with scholars based in Canada, France and United States. Matthieu Blanchet's co-authors include Camille Sureau, Patrick Labonté, Andrew Vaillant, Nabil G. Seidah, Yann Le Duff, Matthieu Lemasson, Frauke Beilstein, Carl Guévin, Françoise Berby and Isabelle Bordes and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Virology.

In The Last Decade

Matthieu Blanchet

19 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthieu Blanchet Canada 12 447 379 80 72 58 19 550
Peter D. Block United States 8 230 0.5× 197 0.5× 74 0.9× 103 1.4× 79 1.4× 17 457
Sayuri Nitta Japan 15 408 0.9× 489 1.3× 104 1.3× 107 1.5× 170 2.9× 40 681
Lionello Ruggeri Italy 8 363 0.8× 409 1.1× 76 0.9× 106 1.5× 89 1.5× 10 626
Corinna M. Bremer Germany 11 470 1.1× 405 1.1× 63 0.8× 68 0.9× 59 1.0× 13 552
Marie–Sophie Hiet Germany 7 430 1.0× 532 1.4× 66 0.8× 159 2.2× 84 1.4× 8 697
Minoru Sakamoto Japan 16 440 1.0× 458 1.2× 127 1.6× 63 0.9× 22 0.4× 28 659
Wakana Saso Japan 8 294 0.7× 206 0.5× 93 1.2× 112 1.6× 41 0.7× 10 436
Laura Heydmann France 14 414 0.9× 383 1.0× 114 1.4× 106 1.5× 163 2.8× 24 635
Allan G. N. Angus United Kingdom 11 334 0.7× 438 1.2× 37 0.5× 123 1.7× 54 0.9× 12 560
Kathrin Hueging Germany 10 318 0.7× 398 1.1× 51 0.6× 80 1.1× 38 0.7× 10 511

Countries citing papers authored by Matthieu Blanchet

Since Specialization
Citations

This map shows the geographic impact of Matthieu Blanchet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthieu Blanchet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthieu Blanchet more than expected).

Fields of papers citing papers by Matthieu Blanchet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthieu Blanchet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthieu Blanchet. The network helps show where Matthieu Blanchet may publish in the future.

Co-authorship network of co-authors of Matthieu Blanchet

This figure shows the co-authorship network connecting the top 25 collaborators of Matthieu Blanchet. A scholar is included among the top collaborators of Matthieu Blanchet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthieu Blanchet. Matthieu Blanchet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Blanchet, Matthieu, et al.. (2024). HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression. Viruses. 16(4). 532–532. 1 indexed citations
2.
Blanchet, Matthieu, et al.. (2024). Exosomes as Conduits: Facilitating Hepatitis B Virus-Independent Hepatitis D Virus Transmission and Propagation in Hepatocytes. Viruses. 16(6). 825–825. 3 indexed citations
3.
Vaillant, Andrew, et al.. (2023). Pangenomic antiviral effect of REP 2139 in CRISPR/Cas9 engineered cell lines expressing hepatitis B virus surface antigen. PLoS ONE. 18(11). e0293167–e0293167. 1 indexed citations
4.
Blanchet, Matthieu, et al.. (2020). Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro. Antiviral Research. 183. 104853–104853. 46 indexed citations
5.
Blanchet, Matthieu, et al.. (2019). Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells. Antiviral Research. 164. 97–105. 49 indexed citations
6.
Sureau, Camille, et al.. (2019). Hepatitis Delta Virus Alters the Autophagy Process To Promote Its Genome Replication. Journal of Virology. 94(4). 18 indexed citations
7.
8.
Berby, Françoise, Isabelle Bordes, O. Hantz, et al.. (2017). Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes. PLoS ONE. 12(6). e0179697–e0179697. 24 indexed citations
9.
Blanchet, Matthieu, et al.. (2017). Dose-response relationships in gene expression profiles in a harbor seal B lymphoma cell line exposed to 17α-ethinyl estradiol. Journal of Xenobiotics. 7(1). 6702–6702. 1 indexed citations
10.
Blanchet, Matthieu, Andrew Vaillant, & Patrick Labonté. (2017). Post-entry antiviral effects of nucleic acid polymers against hepatitis B virus infection in vitro. Journal of Hepatology. 66(1). S257–S257. 3 indexed citations
11.
Beilstein, Frauke, Matthieu Blanchet, Andrew Vaillant, & Camille Sureau. (2017). Nucleic Acid Polymers Are Active against Hepatitis Delta Virus InfectionIn Vitro. Journal of Virology. 92(4). 33 indexed citations
12.
Blanchet, Matthieu, et al.. (2016). Statins can exert dual, concentration dependent effects on HCV entry in vitro. Antiviral Research. 128. 43–48. 10 indexed citations
13.
Blanchet, Matthieu, Camille Sureau, Carl Guévin, Nabil G. Seidah, & Patrick Labonté. (2015). SKI-1/S1P inhibitor PF-429242 impairs the onset of HCV infection. Antiviral Research. 115. 94–104. 32 indexed citations
14.
15.
Blanchet, Matthieu, Camille Sureau, & Patrick Labonté. (2014). Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle. Antiviral Research. 106. 111–115. 63 indexed citations
16.
Blanchet, Matthieu, Nabil G. Seidah, & Patrick Labonté. (2012). SKI-1/S1P inhibition: A promising surrogate to statins to block Hepatitis C virus replication. Antiviral Research. 95(2). 159–166. 25 indexed citations
17.
Duff, Yann Le, Matthieu Blanchet, & Camille Sureau. (2009). The Pre-S1 and Antigenic Loop Infectivity Determinants of the Hepatitis B Virus Envelope Proteins Are Functionally Independent. Journal of Virology. 83(23). 12443–12451. 51 indexed citations
18.
Blanchet, Matthieu & Camille Sureau. (2007). Infectivity Determinants of the Hepatitis B Virus Pre-S Domain Are Confined to the N-Terminal 75 Amino Acid Residues. Journal of Virology. 81(11). 5841–5849. 107 indexed citations
19.
Blanchet, Matthieu & Camille Sureau. (2006). Analysis of the Cytosolic Domains of the Hepatitis B Virus Envelope Proteins for Their Function in Viral Particle Assembly and Infectivity. Journal of Virology. 80(24). 11935–11945. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter D. Block Breakdown of academic impact, for papers by Sayuri Nitta Breakdown of academic impact, for papers by Lionello Ruggeri Breakdown of academic impact, for papers by Corinna M. Bremer Breakdown of academic impact, for papers by Marie–Sophie Hiet Breakdown of academic impact, for papers by Minoru Sakamoto Breakdown of academic impact, for papers by Wakana Saso Breakdown of academic impact, for papers by Laura Heydmann Breakdown of academic impact, for papers by Allan G. N. Angus Breakdown of academic impact, for papers by Kathrin Hueging
Rankless by CCL
2026